Genomics & Precision MedicineTranslation Services

All genomics translators on our team hold advanced degrees (MSc or PhD) in molecular biology, genetics, bioinformatics, biochemistry, or a related discipline. Many have direct research experience in genomics laboratories or regulatory affairs roles at genomics companies. We do not use general medical translators for genomics documents — the scientific complexity requires specialist expertise.

Yes. We have extensive experience translating IND, CTA, and BLA filings for gene therapy products for both FDA (OTAT) and EMA (CAT). Our regulatory specialists understand the specific content requirements for AAV-based gene therapies, lentiviral vector products, and mRNA therapeutics, including manufacturing process descriptions, preclinical safety data, and clinical protocols.

We maintain continuously updated genomics terminology databases in all major languages, aligned with HGNC gene nomenclature, ACMG/AMP variant classification standards, and ISCN cytogenetic notation. Our terminology managers monitor publications from NCBI, EMBL-EBI, and major genomics journals to ensure our glossaries reflect current scientific usage.

Yes. We provide integrated translation services for co-developed drug and companion diagnostic programs, ensuring that biomarker definitions, assay descriptions, and clinical performance data are translated consistently across both the drug NDA/BLA and the companion diagnostic 510(k)/PMA. This is critical for FDA submissions where the drug and CDx are reviewed together.

Yes. We translate clinical genomic test reports, patient-facing variant interpretation summaries, and genetic counseling materials. These documents require both scientific accuracy and plain-language accessibility. Our translators are trained in health literacy principles and follow ACMG guidelines for variant classification and reporting.

We cover 500+ languages for genomics translations, with particular depth in the major regulatory markets: English, Japanese, Chinese (Simplified and Traditional), German, French, Spanish, Italian, Portuguese, Korean, and Russian. For rare languages, we can typically mobilize qualified genomics translators within 48–72 hours.

All genomics projects are handled under strict mutual NDAs and confidentiality agreements. We use encrypted file transfer, role-based access controls, and secure project management platforms. Our information security practices are aligned with ISO 27001. We do not use AI translation tools for proprietary genomics data without explicit client consent.

Yes. We translate CRISPR and gene editing patent applications in all major patent jurisdictions, including USPTO, EPO, WIPO (PCT), and JPO. Our patent translators combine genomics scientific expertise with patent law knowledge to ensure that claims, specifications, and sequence listings are translated with the precision required for IP protection.